CN101313306B - 用于鉴别鼻咽癌中的预后型亚类的基因表达谱 - Google Patents

用于鉴别鼻咽癌中的预后型亚类的基因表达谱 Download PDF

Info

Publication number
CN101313306B
CN101313306B CN2006800437623A CN200680043762A CN101313306B CN 101313306 B CN101313306 B CN 101313306B CN 2006800437623 A CN2006800437623 A CN 2006800437623A CN 200680043762 A CN200680043762 A CN 200680043762A CN 101313306 B CN101313306 B CN 101313306B
Authority
CN
China
Prior art keywords
gene
risk
genes
expression
npc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2006800437623A
Other languages
English (en)
Chinese (zh)
Other versions
CN101313306A (zh
Inventor
K-j·高
A·黄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Synthetic Rubber Corp
Original Assignee
China Synthetic Rubber Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Synthetic Rubber Corp filed Critical China Synthetic Rubber Corp
Publication of CN101313306A publication Critical patent/CN101313306A/zh
Application granted granted Critical
Publication of CN101313306B publication Critical patent/CN101313306B/zh
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Public Health (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Signal Processing (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN2006800437623A 2005-09-22 2006-09-22 用于鉴别鼻咽癌中的预后型亚类的基因表达谱 Active CN101313306B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US71917105P 2005-09-22 2005-09-22
US60/719,171 2005-09-22
US72112905P 2005-09-28 2005-09-28
US60/721,129 2005-09-28
PCT/US2006/037203 WO2007038402A1 (en) 2005-09-22 2006-09-22 Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201110276634.6A Division CN102346816B (zh) 2005-09-22 2006-09-22 用于鉴别鼻咽癌中的预后型亚类的基因表达谱

Publications (2)

Publication Number Publication Date
CN101313306A CN101313306A (zh) 2008-11-26
CN101313306B true CN101313306B (zh) 2011-11-16

Family

ID=37596251

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2006800437623A Active CN101313306B (zh) 2005-09-22 2006-09-22 用于鉴别鼻咽癌中的预后型亚类的基因表达谱
CN201110276634.6A Active CN102346816B (zh) 2005-09-22 2006-09-22 用于鉴别鼻咽癌中的预后型亚类的基因表达谱

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201110276634.6A Active CN102346816B (zh) 2005-09-22 2006-09-22 用于鉴别鼻咽癌中的预后型亚类的基因表达谱

Country Status (13)

Country Link
US (1) US7998674B2 (enExample)
EP (1) EP1934862A1 (enExample)
JP (1) JP2009516501A (enExample)
KR (1) KR20080063343A (enExample)
CN (2) CN101313306B (enExample)
AU (1) AU2006294880A1 (enExample)
BR (1) BRPI0616139A2 (enExample)
CA (1) CA2623403A1 (enExample)
IL (1) IL190253A0 (enExample)
NO (1) NO20081925L (enExample)
RU (1) RU2008115113A (enExample)
TW (1) TW200729050A (enExample)
WO (1) WO2007038402A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
WO2009085196A1 (en) * 2007-12-21 2009-07-09 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US9684001B2 (en) 2008-02-07 2017-06-20 Ranju Ralhan Biomarkers for head-and-neck cancers and precancers
CA2618163A1 (en) * 2008-02-07 2009-08-07 K. W. Michael Siu Head and neck cancer biomarkers
CA2725978A1 (en) 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
WO2010030167A2 (en) * 2008-09-12 2010-03-18 Cancer Research Initiative Foundation Method of detection and diagnosis of oral and nasopharyngeal cancers
EP3831954A3 (en) * 2008-11-17 2021-10-13 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) * 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
EP3360978A3 (en) 2009-05-07 2018-09-26 Veracyte, Inc. Methods for diagnosis of thyroid conditions
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
WO2011116380A2 (en) 2010-03-19 2011-09-22 H. Lee Moffitt Cancer Center And Research Institute, Inc. Hybrid model for the classification of carcinoma subtypes
EP2611943B1 (en) 2010-09-03 2017-01-04 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
EP2791359B1 (en) 2011-12-13 2020-01-15 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
CN102732484B (zh) * 2012-07-10 2015-04-22 广东医学院 一种人鼻咽癌肿瘤干细胞系建立方法
ES3015226T3 (en) 2012-08-16 2025-04-30 Veracyte Sd Inc Prostate cancer prognosis using biomarkers
CN103020454A (zh) * 2012-12-15 2013-04-03 中国科学院深圳先进技术研究院 发病关键因素提取与疾病预警方法及系统
KR101711584B1 (ko) * 2012-12-18 2017-03-02 재단법인 의약바이오컨버젼스연구단 변형된 eprs 단백질의 결정 구조 및 이의 결정화 방법
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
CN114606309A (zh) 2014-11-05 2022-06-10 威拉赛特公司 使用机器学习和高维转录数据的诊断系统和方法
EP3504348B1 (en) 2016-08-24 2022-12-14 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
WO2018132916A1 (en) 2017-01-20 2018-07-26 Genomedx Biosciences, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
AU2018230784A1 (en) 2017-03-09 2019-10-10 Decipher Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
WO2018205035A1 (en) 2017-05-12 2018-11-15 Genomedx Biosciences, Inc Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
WO2019028285A2 (en) 2017-08-04 2019-02-07 Genomedx, Inc. USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY
CN109801680B (zh) * 2018-12-03 2023-02-28 广州中医药大学(广州中医药研究院) 基于tcga数据库的肿瘤转移复发预测方法及系统
CN111382217B (zh) * 2018-12-29 2025-06-24 北京奇虎科技有限公司 一种目的地推荐方法和装置
CN120473159B (zh) * 2025-07-14 2025-09-26 泛肽生物科技(浙江)有限公司 一种鼻咽癌远处转移预测模型的构建方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1445546A (zh) * 2003-01-08 2003-10-01 中山大学肿瘤防治中心 鼻咽癌早期诊断试剂盒
CN1482256A (zh) * 2002-09-13 2004-03-17 中南大学 鼻咽癌分子标志物—brd7试剂盒
CN1643377A (zh) * 2002-01-23 2005-07-20 吴俊贤;许锦文 检验和治疗鼻咽癌的物质和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143539A1 (en) 2000-12-08 2003-07-31 Francois Bertucci Gene expression profiling of primary breast carcinomas using arrays of candidate genes
US20030014539A1 (en) * 2001-06-12 2003-01-16 Reznick Josh L. System and method for traffic management
US20040009518A1 (en) * 2002-05-14 2004-01-15 The Chinese University Of Hong Kong Methods for evaluating a disease condition by nucleic acid detection and fractionation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1643377A (zh) * 2002-01-23 2005-07-20 吴俊贤;许锦文 检验和治疗鼻咽癌的物质和方法
CN1482256A (zh) * 2002-09-13 2004-03-17 中南大学 鼻咽癌分子标志物—brd7试剂盒
CN1445546A (zh) * 2003-01-08 2003-10-01 中山大学肿瘤防治中心 鼻咽癌早期诊断试剂盒

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
li shen et al.Dimension Reduction-Based Penalized Logistic Regression for Cancer Classification Using Microarray Data.IEEE/ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS.2005,2(2),166-175. *
Norio Iizuka et al.Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.MECHANISMS OF DISEASE.2003,361923-929. *

Also Published As

Publication number Publication date
CN101313306A (zh) 2008-11-26
CA2623403A1 (en) 2007-04-05
CN102346816A (zh) 2012-02-08
CN102346816B (zh) 2014-12-03
WO2007038402A1 (en) 2007-04-05
NO20081925L (no) 2008-06-20
TW200729050A (en) 2007-08-01
US20080281568A1 (en) 2008-11-13
AU2006294880A1 (en) 2007-04-05
US7998674B2 (en) 2011-08-16
RU2008115113A (ru) 2009-10-27
IL190253A0 (en) 2008-11-03
EP1934862A1 (en) 2008-06-25
WO2007038402A9 (en) 2007-07-05
BRPI0616139A2 (pt) 2011-06-07
KR20080063343A (ko) 2008-07-03
JP2009516501A (ja) 2009-04-23

Similar Documents

Publication Publication Date Title
CN102346816B (zh) 用于鉴别鼻咽癌中的预后型亚类的基因表达谱
Lee et al. Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets
Lee et al. Prediction of recurrence-free survival in postoperative non–small cell lung cancer patients by using an integrated model of clinical information and gene expression
Wach et al. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening
Miller et al. Optimal gene expression analysis by microarrays
Kozubek et al. In-depth characterization of microRNA transcriptome in melanoma
CN106834462B (zh) 一组胃癌基因的应用
CN102971435B (zh) 用于内分泌治疗下的乳腺癌复发预测的方法
AU2019343931B2 (en) Cell-free DNA hydroxymethylation profiles in the evaluation of pancreatic lesions
US20150299798A1 (en) Method for classification of liver samples and diagnosis of focal nodule dysplasia, hepatocellular adenoma, and hepatocellular carcinoma
JP2009543552A5 (enExample)
JP2010535473A5 (enExample)
JP2008521383A (ja) ｐ５３の状態と遺伝子発現プロファイルとの関連性に基づき、癌を分類し、予後を予測し、そして診断する方法、システム、およびアレイ
Ju et al. Altered expression pattern of circular RNAs in metastatic oral mucosal melanoma
EP2419540B1 (en) Methods and gene expression signature for assessing ras pathway activity
US20110256545A1 (en) mRNA expression-based prognostic gene signature for non-small cell lung cancer
Limame et al. Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer
TW201741915A (zh) 基因表現圖譜以及將其應用於乳癌醫療之方法
EP2808815A2 (en) Identification of biologically and clinically essential genes and gene pairs, and methods employing the identified genes and gene pairs
EP3144395B1 (en) Microrna signature as an indicator of the risk of early recurrence in patients with breast cancer
Hesse et al. Genome-wide small RNA sequencing and gene expression analysis reveals a microRNA profile of cancer susceptibility in ATM-deficient human mammary epithelial cells
US20130084241A1 (en) DEVELOPMENT OF miRNA DIAGNOSTICS TOOLS IN BLADDER CANCER
Sparano et al. Clinical application of gene expression profiling in breast cancer
CN110055332A (zh) 与甲状腺癌相关的标志物及其应用
CN110452989B (zh) 生物标志物在胃癌检测、诊断中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant